Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future salesAUSTIN, Texas,...